These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 2517141)
1. Resistance of two strains of Streptococcus pneumoniae to pristinamycin associated with 16-membered macrolides. Emond JP; Fremaux A; Dublanchet A; Sissia G; Geslin P; Sedalian A; Lionsquy G Pathol Biol (Paris); 1989 Sep; 37(7):791-2. PubMed ID: 2517141 [TBL] [Abstract][Full Text] [Related]
2. [Resistance to macrolides, lincosamides and streptogramins in infections by Streptococcus pneumoniae]. Alonso Manzanares MA; Gutíerrez Zufiaurre MN; Muñoz Bellido JL; García-Rodríguez JA Med Clin (Barc); 1998 Feb; 110 Suppl 1():25-30. PubMed ID: 9717157 [No Abstract] [Full Text] [Related]
3. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae. Lozniewski A; Lion C; Mory F; Weber M Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841 [TBL] [Abstract][Full Text] [Related]
4. Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae. Depardieu F; Courvalin P Antimicrob Agents Chemother; 2001 Jan; 45(1):319-23. PubMed ID: 11120988 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of six macrolides, clindamycin and tetracycline on Streptococcus pneumoniae with different penicillin susceptibilities. Poulsen RL; Knudsen JD; Petersen MB; Fuursted K; Espersen F; Frimodt-Møller N APMIS; 1996 Mar; 104(3):227-33. PubMed ID: 8611198 [TBL] [Abstract][Full Text] [Related]
6. [Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood]. Rodríguez-Avial C; García MM; Rodríguez-Avial I; Picazo JJ Rev Esp Quimioter; 1999 Dec; 12(4):346-51. PubMed ID: 10855014 [TBL] [Abstract][Full Text] [Related]
7. Activity of macrolides, lincosamines, streptogramins and fluoroquinolones against streptococcus pneumoniae and enterococci isolates from the western hemisphere: example of international surveillance (SENTRY antimicrobial surveillance program )in the development of new drugs. Lewis MT; Jones RN Braz J Infect Dis; 2000 Feb; 4(1):15-21. PubMed ID: 10788841 [TBL] [Abstract][Full Text] [Related]
9. [Association between MLS antibiotic and tetracycline resistance genes in Streptococcus pneumoniae]. Seral C; Castillo FJ; Rubio-Calvo MC; García C; Gómez-Lus R Rev Esp Quimioter; 2001 Mar; 14(1):55-62. PubMed ID: 11376351 [TBL] [Abstract][Full Text] [Related]
10. Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003. Reinert RR; Franken C; van der Linden M; Lütticken R; Cil M; Al-Lahham A Int J Antimicrob Agents; 2004 Jul; 24(1):43-7. PubMed ID: 15225860 [TBL] [Abstract][Full Text] [Related]
11. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P; Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184 [TBL] [Abstract][Full Text] [Related]
12. [Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens]. Limia A; Jiménez ML; Delgado T; Sánchez I; López S; López-Brea M Rev Esp Quimioter; 1998 Sep; 11(3):216-20. PubMed ID: 9795307 [TBL] [Abstract][Full Text] [Related]
13. Killing kinetics of RP 59500 and pristinamycin against penicillin-resistant pneumococci. Barakett V; Lesage D; Delisle F; Richard G; Petit JC Pathol Biol (Paris); 1997 May; 45(5):438-40. PubMed ID: 9296100 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibilities and distribution of resistance genes for beta-lactams and macrolides in Streptococcus pneumoniae isolated between 2002 and 2004 in Tokyo. Noguchi N; Tano J; Nasu Y; Koyama M; Narui K; Kamishima H; Saito T; Tsuyuki K; Sasatsu M Int J Antimicrob Agents; 2007 Jan; 29(1):26-33. PubMed ID: 17189091 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of macrolide resistance in clinical pneumococcal isolates in France. Fitoussi F; Doit C; Geslin P; Brahimi N; Bingen E Antimicrob Agents Chemother; 2001 Feb; 45(2):636-8. PubMed ID: 11158772 [TBL] [Abstract][Full Text] [Related]
16. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004). Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477 [TBL] [Abstract][Full Text] [Related]